Dr.
Atin Kumar
Male
Affiliation
Professor, Trauma Centre Division
Department of
Radio Diagnosis
Contact
Email :
dratinkumar[at]gmail[dot]com
Dr.
Shivanand Gamanagatti
Male
Affiliation
Professor, Trauma Centre Division
Department of
Radio Diagnosis
Contact
Email :
shiv223[at]gmail[dot]com
Dr.
Smriti Hari
Female
Affiliation
Professor
Department of
Radio Diagnosis
Contact
Email :
smritihari[at]gmail[dot]com
Prof.
Ashu Seith Bhalla
Female
Affiliation
Professor
Department of
Radio Diagnosis
Contact
Email :
ashubhalla1[at]yahoo[dot]com
Prof.
Sanjay Tulkar
Male
Affiliation
Professor, Deptt of Radiology, IRCH
Department of
Radio Diagnosis
Prof.
Sanjay Sharma
Male
Affiliation
Professor (RPC)
Department of
Radio Diagnosis
Contact
Email :
drssharma[at]hotmail[dot]com
Prof.
Raju Sharma
Male
Affiliation
Professor and Head of Department
Department of
Radio Diagnosis
Contact
Email :
raju152[at]yahoo[dot]com
Dr.
Harlokesh Narayan Yadav
Male
Affiliation
Associate Professor
Department of
Pharmacology
Contact
Email :
hnyadav[at]gmail[dot]com
Phone :
26549272
011-26548565
Memberships
- Serving as Secretary International of Indian Pharmacological Society, India
- National Academy of Medical Sciences, New Delhi
- Life Member of Indian Pharmacological Society (IPS)
- Life Member of Indian Society of Nanomedicine
- Life member of InPharm Association
- Life member of Indian Pharmacy Graduates Association (IPGA)
GUIDED: 40 PG Students
Experience: 13 Years of academic and research experience
1. Gold medal for Dr. Manjeet Singh Award for best research work in the area of molecular Pharmacology by Indian Pharmacological Society.
2 . Gold medal for N.N. Datta Prize for best published work in Indian Journal of Pharmacology by Indian Pharmacological Society.
Research Interests:
Teaching: Involved in the Undergraduate and Post graduate teaching (MBBS and MD) and mentoring PhD students in All India Institute of Medical Sciences, New Delhi
Research:
Major Area: Molecular Pharmacology/Cardiovascular Pharmacology/Nano-Pharmacology
Cardiac ischemic-reperfusion injury, cardiac hypertrophy, cardiac failure and Pulmonary artery hypertension and In Vitro Screening
Selected Research Publications
Dr.
Pooja Gupta
Female
MD, DM, MAMS
Affiliation
Professor
Department of
Pharmacology
Contact
Email :
drgupta[dot]pooja[at]aiims[dot]edu
Phone :
91-11-26549257
Office Address
Address: Room No 5004, 5th Floor, Department of Pharmacology, Convergence Block, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029
Areas of Interests: Clinical Pharmacology, oncopharmacology, pharmacovigilance, regulatory pharmacology, pharmacoeconomics, bioethics
Academic details:
- DM (Clinical Pharmacology), All India Institute of Medical Sciences, New Delhi.
- MD (Pharmacology), Maulana Azad Medical College, New Delhi
- MBBS, Lady Hardinge Medical College, New Delhi
- Professor-in-charge, Computer Facility
- AIIMS center coordinator for adverse event monitoring of drugs and medical devices under Pharmacovigilance Program of India and Materiovigilance Program of India
- Member secretary, Institute Ethics Sub-Committee for SAEs in Clinical Trials, AIIMS
- Member and Workshop Coordinator, Working Committee, Clinical research unit, AIIMS, New Delhi
- Member, National Adverse Events Following Immunization (AEFI) Subcommittees (causality assessment and advocacy & media), MoH&FW, GoI
- Member, Subcommittee for medicines under Standing National Committee on Medicines and other Health Care Products, MoH&FW, GoI
- Involved in >15 research projects funded by ICMR, DST, AIIMS, AYUSH, Govt. of India; Guided >20 theses as Guide/Co-guide (PhD/DM/MD/MS/MDS/MSc); and have >40 publications with an h-index of 13.
- Malhotra S, Kalaivani M, Lodha R, Bakhshi S, Mathur V, Gupta P, Kedia S, Sankar J, Kumar P, Kumar A, Ahuja V, Sinha S, Guleria R, COVID Reinfection AIIMS Consortium. COVID-19 infection, and reinfection, and vaccine effectiveness against symptomatic infection among health care workers in the setting of omicron variant transmission in New Delhi, India. Lancet Reg Health Southeast Asia. 2022. DOI: 10.1016/j.lansea.2022.100023.
- Malhotra S, Kalaivani M, Lodha R, Bakhshi S, Mathur V, Gupta P, Kedia S, Sankar J, Kumar P, Kumar A, Ahuja V, Sinha S, Guleria R, COVID Reinfection AIIMS Consortium. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India. JAMA Network Open. 2022;5(1):e2142210. DOI: 10.1001/jamanetworkopen.2021.42210
- Kajal S, Naeem SS, Gupta P*, Kairo AK, Ahmed A, Verma P, Saini A. Sinonasal mucormycosis and liposomal amphotericin B: A quest for dose optimization. Ind J Pharmacol. 2022;54(2):90-96.
- Gupta P, Naeem SS, Mohan P, Banerjee A. Is written informed consent cast in iron even during a Pandemic? [Editorial]. Med J Armed Forces India. 2020;76:367-9.
- Diksha, Gupta P*, Malik PS, Mohan A. A pilot study of oxidative and inflammatory markers as early indicator for response to platinum-based chemotherapy in non-small cell lung cancer patients. J Clin Pharm Ther. 2019; 00: 1– 6. https://doi.org/10.1111/jcpt.13053
- Gupta P, Anvikar A, Valecha N, Gupta YK. Pharmacovigilance Practices for Better Healthcare Delivery: Knowledge and Attitude Study in the National Malaria Control Programme of India. Malar Res Treat 2014; 2014: 837427. doi:10.1155/2014/837427
- Gupta P, Mehla J, Gupta YK. Antiobesity effect of Safoof Mohazzil, a Unani herbal formulation, in cafeteria diet induced obesity in rats. Indian J Exp Biol 2012; 50: 776-84.
- Gupta P, Gupta V, Gupta YK. Anticancer Phase I Clinical Trials in Healthy Volunteers: need for critical consideration. Indian J Pharmacol. 2012; 44: 540-42.
- Padhy BM, Gupta P, Gupta YK. Analysis of the compliance of informed consent documents with good clinical practice guideline. Contemp Clin Trials. 2011; 32: 662-666.
- Gupta P, Roy V, Sethi GR, Mishra TK. Pyrazinamide blood concentrations in children suffering from tuberculosis: a comparative study at two doses. Br J Clin Pharmacol. 2008; 65(3): 423-427.
Dr.
JAGRITI BHATIA
Female
Affiliation
Professor
Department of
Pharmacology
Contact
Email :
jagriti2012[at]rediffmail[dot]com
Phone :
011-2654 6476
26593282
Education:
MBBS (Lady Hardinge Medical College, New Delhi, 1995)
MD Pharmacology (UCMS-GTB Hospital, Delhi, 1999)
Departmental duties:
Engaged in teaching of MBBS (3rd, 4th and 5th Semester), BSc Nursing (Hons), MSc, MD and PhD students
AIIMS Excellence Research Award 2015 Commendation Certificate for the year 2014-2015. ISH 2014 International Forum Poster Prize for the Asia and Australasia Region at Athens, Greece, 2014.
Field of Research:
Herbal (Indigenous) Pharmacology
Cardiovascular Pharmacology
Nephrotoxicity
Pulmonary fibrosis
- Gamad N, Malik S, Suchal K, Vasisht S, Tomar A, Arava S, Arya DS, Bhatia J. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms. Biomed Pharmacother 2018; 97: 1544–1553.
- Khan SI, Malhotra RK, Rani N, Sahu AK, Tomar A, Garg S, Nag TC, Ray R, Ojha S, Arya DS, Bhatia J. Febuxostat Modulates MAPK/NF-κBp65/TNF-α Signaling in Cardiac Ischemia-Reperfusion Injury.Oxid Med Cell Longev. 2017;2017:8095825.
- Tomar A, Vasisth S, Khan SI, Malik S, Nag TC, Arya DS, Bhatia J. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade. Phytomedicine.2017;34:154-161.
- Malik S, Suchal K, Khan SI, Bhatia J, Kishore K, Dinda AK, Arya DS. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK/NF-κB/TNFα and TGF-β1/MAPK/Fibronectin pathways.Am J Physiol Renal Physiol.2017;313(2):F414-F422.
- Suchal K, Malik S, Gamad N, Malhotra RK, Goyal SN, Bhatia J, Arya DS. Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.Phytomedicine. 2016;23(12):1401-1408.
- Malik S, Suchal K, Bhatia J, Khan SI, Vasisth S, Tomar A, Goyal S, Kumar R, Arya DS, OjhaSK.Therapeutic Potential and Molecular Mechanisms of Emblica officinalisGaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin. Front Pharmacol 2016;7:350. eCollection 2016.
- Rani N, Bharti S, Tomar A, Dinda AK, Arya DS, Bhatia J. Inhibition of PARP activation by enalapril is crucial for its renoprotective effect in cisplatin-induced nephrotoxicity in rats.Free Radic Res 2016;50(11):1226-1236.
- Malik S, Suchal K, Bhatia J, Gamad N, Dinda AK, Gupta YK, Arya DS. Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechingallate. Lab Invest.2016; 96(8):853-61.
- Malik S, Suchal K, Gamad N, Dinda AK, Arya DS, Bhatia J .Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis.Eur J Pharmacol. 2015; 748:54-60.
